SUMC in the News (11/07/06)
Print media coverage
New York Times, 11/07/06
Treatment: M.R.I. scans said to aid stroke assessment
This Vital Signs article discusses a report from Stanford researchers in the Annals of Neurology about new magnetic resonance imaging techniques that can discriminate between stroke patients who are likely to benefit from stroke medication. Gregory Albers, professor of neurology and neurological sciences, is mentioned.
Philadelphia Inquirer, 11/07/06
New hope on gene therapy
A novel gene therapy that uses a genetic version of a Trojan horse has shown promise in fighting the AIDS virus. Mark Kay, the Dennis Farrey Family Professor in Pediatrics, provides comment. This article appears in numerous other newspapers, including the Columbus Ledger-Enquirer (Columbus, Ohio), Contra Costa Times, Kansas City Star, Monterey County Herald and San Luis Obispo Tribune.
Orlando Sentinel, 11/07/06
Another myth says buy, buy
A recent Stanford study suggests men are nearly as likely as women to suffer from compulsive buying disorder. Lorrin Koran, emeritus professor in psychiatry and behavioral sciences, is mentioned. This article originally appeared in the San Jose Mercury News.
Associated Press, 11/07/06
Australian Senate OKs cloning embryos
Australia's Senate narrowly voted Tuesday to lift the country's ban on cloning human embryos for stem cell research. The House of Representatives still needs to pass the bill before it becomes law, but lawmakers had expected the Senate to pose the biggest hurdle. Stanford is not mentioned in this story, but it may be of interest to readers.
Washington Post, 11/06/06
Are you at risk for eating disorders?
Stanford researchers have developed a quiz as part of its "Student Bodies" eating-disorders prevention program. The quiz also appears in the Charlotte Observer (Charlotte, N.C.).
MSBNC.com, 11/06/06
The stem cell spin
In several states, stem cell research could play a role in the outcome of today's elections. This blog entry discusses the situation; a WebMD.com piece also discusses how campaign ads have done little to inform voters about the real, scientific issues surrounding stem cells. Although Stanford isn't referenced, these pieces may be of interest to readers.
Office of Communication